Page 12 - Pharmaceutical
Alivira's animal health API facility gets US FDA approval
Approval will enable SeQuent Scientific arm to enter the $ 8-bn US veterinary healthcare market
 "Alivira's animal health API facility gets US FDA approval")
Govt's aim is to make IPR policy more efficient: Nirmala Sitharaman
India's IPR policy is TRIPS compliant and forward looking, says the Minister of Commerce & Industry
 "Govt's aim is to make IPR policy more efficient: Nirmala Sitharaman")
Glenmark starts clinical trial for biosimilar used to treat allergic asthma
The reference product for this biosimilar is omalizumab, sold under the brand name Xolair
 "Glenmark starts clinical trial for biosimilar used to treat allergic asthma")
Amgen & Novartis expand collaboration for migraine drug Erenumab
It builds on their global neuroscience partnership in Alzheimer's disease & migraine formed in 2015
 "Amgen & Novartis expand collaboration for migraine drug Erenumab")
Merck sells biosimilars business to Fresenius to focus on innovative drugs
Merck to receive upfront payment of € 170 mn & milestone payments of up to € 500 mn on future sales
 "Merck sells biosimilars business to Fresenius to focus on innovative drugs")
US FDA issues warning letter for Divi's Laboratories' Visakhapatnam unit
Last month, US drug regulator had issued an import alert on the products manufactured from this unit
 "US FDA issues warning letter for Divi's Laboratories' Visakhapatnam unit")
Avantor Performance Materials acquires Puritan Products
Deal to enhance Avantor's portfolio of high-purity cGMP materials & solutions for biopharma industry
 "Avantor Performance Materials acquires Puritan Products")
Sawai Pharmaceutical buys Upsher?Smith's generics business for $1.05 bn
The acquisition will mark a major expansion of Sawai's presence in the US market
 "Sawai Pharmaceutical buys Upsher?Smith's generics business for $1.05 bn")
BioInvent to use Merck's bioreactors to expand Swiss facility
Addition of single-use Mobius bioreactors to streamline BioInvent's drug development & production
 "BioInvent to use Merck's bioreactors to expand Swiss facility")
Bain Capital & Cinven buy German generic drug maker Strada for € 4.1 bn
Stada offers a portfolio of high-quality, low-cost generic products including selected biosimilars
 "Bain Capital & Cinven buy German generic drug maker Strada for € 4.1 bn")
Winning strategies for companies to succeed in ever-changing pharma market
Pharma leaders need to take swift steps to get ahead of emerging changes, says Utkarsh Palnitkar
 "Winning strategies for companies to succeed in ever-changing pharma market")
Cipla to collaborate with US-based MEDRx for muscle relaxant drug
As per the deal, MEDRx to receive upfront payment of about $ 30 mn & will be eligible for royalties
 "Cipla to collaborate with US-based MEDRx for muscle relaxant drug")
IoT can help pharma industry to overcome quality challenges: Study
Assocham-Sathguru joint study urges government to reduce the dependency on China for APIs
 "IoT can help pharma industry to overcome quality challenges: Study")
Sun Pharma's partner Almirall applies for psoriasis drug approval in Europe
Two firms had entered into a licensing agreement for investigational drug tildrakizumab in July 2016
 "Sun Pharma's partner Almirall applies for psoriasis drug approval in Europe")
Mylan inks settlement pact with Genentech & Roche on cancer drug Herceptin
Trastuzumab (Herceptin) is one of the 6 biologic products co-developed by Mylan & Biocon
 "Mylan inks settlement pact with Genentech & Roche on cancer drug Herceptin")
US FDA lifts import alert imposed on Sun Pharma's Mohali facility
Move clears the way for supply of products from Mohali facility to the US market
Alkem's Baddi manufacturing facility receives 3 observations from US FDA
US FDA had conducted an inspection at Alkem's Baddi facility from March 2-10, 2017
 "Alkem's Baddi manufacturing facility receives 3 observations from US FDA")
Germany's Merck plans divestment of biosimilars business
Merck has a strategic alliance with India's Dr Reddy's Labs to co-develop multiple cancer drugs
 "Germany's Merck plans divestment of biosimilars business")
Cipla divests animal health business in South Africa & Sub-Saharan Africa
It will sell this business to Ascendis Health for Rand 375 million (about Rs 192 crores)
 "Cipla divests animal health business in South Africa & Sub-Saharan Africa")
Glenmark partners Evestra to market contraceptive product in US
They have signed pact for a generic version of Merck & Co's NuvaRing, a contraceptive vaginal ring